Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Various factors move the S&P 500, including earnings, macro data, rate expectations, and sector rotations. This intro covers the main influences on index direction.
17,835 articlesBiotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
When figma stock popped today, investors watched for catalysts beyond a single headline. This guide breaks down the d...
This week, newmont stock dropped over 10% as traders weighed shifting gold prices and fresh company data. The move hi...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
The surge in late applied digital (apld) stock has many investors asking if the window to buy has closed. This guide ...
Ethereum faces renewed selling pressure after a new weekly sell signal. Traders weigh downside targets to $1,900, the...
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
When shaun white sparks dating rumors, the chatter isn’t just about romance. It can ripple into endorsements, brand m...
A director quietly sold a notable stake in American Superconductor, prompting questions about what it signals for inv...
A shift toward a more hawkish Fed path can reshape how we value large banks. This guide breaks down the math, expecta...
Investors woke up to a move in Comcast shares after strategic news and improving fundamentals. This article breaks do...
Public dating moments, from Broadway nights to kiss moments, can shine a light on money habits and budgeting for coup...